- Stocks
- Financials
- Niva Bupa Health Insurance Company
Niva Bupa Health Insurance Company share price
NSE: NIVABUPAFinancialsInsurance - Life
Niva Bupa Health Insurance Company at a glance
Niva Bupa Health Insurance Company (NSE: NIVABUPA) closed at ₹73.66 on 21 Oct 2026, down 4.34% on the day. With a market capitalisation of ₹13,621 Cr, it ranks 475th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Financials sector; its industry is Insurance - Life.
At its last close the stock traded at 103.7× trailing earnings, against a return on equity of 7.0% in FY25. Over the past year the share price has fallen 4.6%. Its 52-week range is ₹67.50 (24 Mar 2026) to ₹91.40 (31 Jul 2026); the last close is 19.4% below the high. In Q1 FY27, the quarter ended 30 Jun 2026, revenue was ₹2,274 Cr (+86.4% year on year) and net profit ₹138 Cr, on a standalone basis. Promoters held 55.30% of the company as of 30 Jun 2026.
Key numbers
- Market cap
- ₹13,621 CrRank 475 on NSE
- P/E (trailing)
- 103.7×
- Price to book
- 4.67×FY25
- EPS (TTM)
- ₹1.96to Q1 FY27
- ROE
- 7.0%FY25
- ROCE
- 8.4%FY25
- Net profit margin
- 4.0%FY25
- Book value / share
- ₹16.72FY25
- 52-week high
- ₹91.4031 Jul 2026
- 52-week low
- ₹67.5024 Mar 2026
- 1-year return
- −4.6%
- RSI (14-day)
- 38
Returns to 21 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | −4.34% | −5.2% | −6.8% | −14.4% | −4.6% |
Niva Bupa Health Insurance Company quarterly results
| Quarter | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1,213 Cr | ₹1,136 Cr | ₹1,527 Cr | ₹1,220 Cr | ₹1,422 Cr | ₹1,454 Cr | ₹1,972 Cr | ₹2,274 Cr |
| Revenue YoY | +34.8% | +19.6% | +25.4% | +19.8% | +17.2% | +28.0% | +29.1% | +86.4% |
| Net profit | ₹13 Cr | ₹13 Cr | ₹206 Cr | −₹91 Cr | −₹35 Cr | −₹88 Cr | ₹345 Cr | ₹138 Cr |
| Net profit YoY | — | +189.1% | +31.2% | — | −370.9% | −761.9% | +67.5% | — |
| Net margin | 1.1% | 1.2% | 13.5% | −7.5% | −2.5% | −6.0% | 17.5% | 6.1% |
| EPS | ₹0.08 | ₹0.07 | ₹1.13 | −₹0.50 | −₹0.19 | −₹0.47 | ₹1.87 | ₹0.75 |
Niva Bupa Health Insurance Company financials
| Item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | ₹1,183 Cr | ₹1,877 Cr | ₹2,853 Cr | ₹4,115 Cr | ₹5,374 Cr |
| Operating profit | −₹50 Cr | −₹197 Cr | ₹13 Cr | ₹82 Cr | ₹214 Cr |
| Net profit | −₹50 Cr | −₹197 Cr | ₹13 Cr | ₹82 Cr | ₹214 Cr |
| EPS (₹) | −₹0.43 | −₹1.42 | ₹0.09 | ₹0.51 | ₹1.22 |
| Cash from operations | ₹0 Cr | ₹338 Cr | ₹593 Cr | ₹813 Cr | ₹1,654 Cr |
| Total debt | ₹0 Cr | ₹250 Cr | ₹250 Cr | ₹250 Cr | ₹250 Cr |
| Shareholders' equity | ₹577 Cr | ₹506 Cr | ₹828 Cr | ₹2,050 Cr | ₹3,055 Cr |
Niva Bupa Health Insurance Company shareholding pattern
| Holder | 31 Mar 2025 | 30 Jun 2025 | 30 Sep 2025 | 31 Dec 2025 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 55.98% | 55.43% | 55.41% | 55.36% | 55.36% | 55.30% |
| Foreign institutions | 8.90% | 10.76% | 10.72% | 10.32% | 10.60% | 12.09% |
| Domestic institutions | 9.70% | 15.06% | 15.31% | 16.04% | 16.49% | 16.17% |
| Non-institutions | 25.42% | 18.75% | 18.56% | 18.28% | 17.55% | 16.44% |
Niva Bupa Health Insurance Company vs peers
The listed Financials companies nearest to Niva Bupa Health Insurance Company by market capitalisation.
| Company | Price | 1 day | 1 year | Market cap | P/E | ROE |
|---|---|---|---|---|---|---|
| FIVESTARFive-Star Business Finance | ₹493.80 | −1.90% | −5.7% | ₹14,576 Cr | 13.3 | 14.9% |
| SAMMAANCAPSammaan Capital | ₹123.52 | −1.46% | −23.8% | ₹14,385 Cr | 7.7 | −37.6% |
| TMBTamilnad Mercantile Bank | ₹863.45 | −0.87% | +98.5% | ₹13,673 Cr | 10.2 | 13.2% |
| NIVABUPANiva Bupa Health Insurance Company | ₹73.66 | −4.34% | −4.6% | ₹13,621 Cr | 103.7 | 7.0% |
| LLOYDSENGGLLOYDS ENGINEERING WORKS | ₹92.00 | −2.23% | +51.1% | ₹13,619 Cr | 61.7 | 6.8% |
| JSWHLJSW Holdings | ₹11,291.00 | −0.01% | −33.1% | ₹12,533 Cr | 85.5 | 0.4% |
| EDELWEISSEdelweiss Financial Services | ₹129.24 | +1.67% | +17.6% | ₹12,233 Cr | 17.4 | — |
Ask anything about Niva Bupa Health Insurance Company
Pivot answers on the live chart with evidence you can check, and tests strategies against NIVABUPA's own history. Try: “Why has NIVABUPA moved over the last three months?” · “Backtest a 50-day moving-average crossover on NIVABUPA over five years” · “Compare NIVABUPA with FIVESTAR on margins and valuation”
Frequently asked questions about Niva Bupa Health Insurance Company
What is the share price of Niva Bupa Health Insurance Company today?
Niva Bupa Health Insurance Company (NSE: NIVABUPA) last closed at ₹73.66 on 21 Oct 2026. Its 52-week high is ₹91.40 and its 52-week low is ₹67.50.
What is the market cap of Niva Bupa Health Insurance Company?
Niva Bupa Health Insurance Company's market capitalisation is ₹13,621 Cr (₹13,621 Cr) at the 21 Oct 2026 close, ranking 475th among the NSE companies Pivot tracks.
What is the P/E ratio of Niva Bupa Health Insurance Company?
Niva Bupa Health Insurance Company trades at a trailing P/E of 103.7. The median P/E of the 6 closest Financials peers by market cap is 17.4.
What is the ROE and ROCE of Niva Bupa Health Insurance Company?
Return on equity was 7.0% in FY25 and return on capital employed was 8.4% in FY25 (standalone figures).
What were Niva Bupa Health Insurance Company's latest quarterly results?
For Q1 FY27 (quarter ended 30 Jun 2026), Niva Bupa Health Insurance Company reported revenue of ₹2,274 Cr, +86.4% year on year, and net profit of ₹138 Cr.
How has Niva Bupa Health Insurance Company stock performed over the last year?
Niva Bupa Health Insurance Company's share price has fallen 4.6% over the past year, −14.4% over three months and −6.8% over one month, to the 21 Oct 2026 close.
What is the shareholding pattern of Niva Bupa Health Insurance Company?
As of 30 Jun 2026: promoters 55.30%, foreign institutions 12.09%, domestic institutions 16.17%, non-institutions 16.44%.
Who are Niva Bupa Health Insurance Company's competitors?
The listed Financials companies closest to Niva Bupa Health Insurance Company by market cap are Five-Star Business Finance, Sammaan Capital, Tamilnad Mercantile Bank, LLOYDS ENGINEERING WORKS, JSW Holdings and Edelweiss Financial Services.
Is Niva Bupa Health Insurance Company a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out Niva Bupa Health Insurance Company's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on NIVABUPA against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 21 Oct 2026 (returns and ratios at the 21 Oct 2026 close). Fundamentals: company filings via Moneycontrol, standalone where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Financials stocks · companies starting with N · all NSE stocks · this page as text